MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.600
-0.070 (-2.62%)
Feb 21, 2025, 4:00 PM EST - Market closed
MEI Pharma Employees
MEI Pharma had 28 employees as of June 30, 2024. The number of employees decreased by 18 or -39.13% compared to the previous year.
Employees
28
Change (1Y)
-18
Growth (1Y)
-39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,364,893
Market Cap
17.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MEIP News
- 10 days ago - MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - Business Wire
- 3 months ago - MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position - Business Wire
- 5 months ago - MEI Pharma Reports Fiscal Year End 2024 Cash Position - Business Wire
- 6 months ago - MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives - Business Wire
- 7 months ago - MEI Pharma to Consider Strategic Alternatives - Business Wire
- 10 months ago - Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP) - Business Wire
- 10 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights - Business Wire
- 11 months ago - MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 - Business Wire